Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
4.780
+0.230 (5.05%)
At close: Oct 15, 2026, 4:00 PM EDT
4.770
-0.010 (-0.21%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $172.35 million as of October 15, 2026. It is the 21,710th most valuable company in the world and the 3,702nd biggest in the United States. Its market cap has decreased by 20.00% in one year.
Market Cap
172.35M
Enterprise Value
-2.11M
1-Year Change
-20.00%
Global Rank
Country Rank
#3,702 United States
Category
ChartMarket Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has decreased from $251.01M to $172.35M, a decrease of -31.34%. That is a compound annual growth rate of -7.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 172.35M | -53.25% |
| Dec 31, 2025 | 368.66M | -39.78% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
| Oct 29, 2021 | 251.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 174.10M |
| Oramed Pharmaceuticals | 172.21M |
| Whitehawk Therapeutics | 169.32M |
| NervGen Pharma | 168.27M |
| Precision BioSciences | 166.44M |
| Coherus Oncology | 162.23M |
| PepGen | 161.03M |
| Compass Therapeutics | 158.30M |